ArticleBMJ open diabetes research & care2019

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands.

Barnaby Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.